Change Location
Set Price Drop Alert for:
NAN PRO-1 INFANT
- QTY 360
- 2.1 G/100
- Powder
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
NAN PRO-1 INFANT
- QTY 360
- 2.1 G/100
- Powder
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
NAN PRO-1 INFANT Lifestyle Interactions
-
Mexiletine Hydrochloride 150mg, Oral capsule
• Interaction: Cannabis• Severity: Major• Notes for Consumers: Discuss cannabis use with your care team. The effects of your medication may be altered if used with cannabis.• Notes for Professionals: Advise patients to avoid cannabis use during mexiletine treatment due to decreased exposure of mexiletine which may alter its efficacy. Cannabis use induces CYP1A2 and mexiletine is a CYP1A2 substrate. The induction potential of cannabis is greatest with chronic inhalation. Other routes of administration or sporadic use may have less of an effect. -
Mexiletine Hydrochloride 150mg, Oral capsule
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during mexiletine treatment due to the risk for increased mexiletine exposure and adverse reactions. Mexiletine is a CYP2D6 substrate and grapefruit juice is a CYP2D6 inhibitor. -
Mexiletine Hydrochloride 150mg, Oral capsule
• Interaction: Tobacco• Severity: Major• Notes for Consumers: Do not smoke or use tobacco products while taking this medication. When used together, your medication may not work as well for you.• Notes for Professionals: Advise patients to avoid tobacco products while receiving mexiletine. Tobacco smoking has been noted to significantly enhance the rate of elimination of mexiletine, possibly leading to subtherapeutic clinical effects. Mexiletine is a CYP1A2 substrate and smoking tobacco induces CYP1A2.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
